Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
MPS Limited ( (IN:MPSLTD) ) has issued an update.
MPS Limited has completed the acquisition of Unbound Medicine, Inc. in the U.S. through its wholly owned subsidiary, MPS North America LLC, following the execution of a stock purchase agreement signed on January 30, 2026. The deal, valued at USD 16.50 million subject to customary adjustments, gives MPS NA LLC 100% ownership of Unbound Medicine and converts the U.S. firm into a wholly owned step-down subsidiary of MPS Limited.
The transaction closed after satisfaction of customary conditions, with the full completion consideration paid at closing as per the agreed terms. The acquisition strengthens MPS Limited’s operational footprint in North America and signals a deeper push into technology-driven, specialized content offerings for healthcare and related professional markets, with potential implications for the company’s growth trajectory and competitive positioning in global knowledge services.
More about MPS Limited
MPS Limited operates in the content and learning solutions industry, serving global publishers, enterprises, and educational institutions with digital publishing, workflow, and technology-enabled services. Through its North American arm, MPS North America LLC, the company has been expanding its presence in the U.S. market, particularly in specialized and professional content segments.
Average Trading Volume: 1,323
Technical Sentiment Signal: Hold
Current Market Cap: 28.15B INR
Learn more about MPSLTD stock on TipRanks’ Stock Analysis page.